What is the average price target for KEMPHARM INC (KMPH) stock?
9 analysts have analysed KMPH and the average price target is 22.78 USD. This implies a price increase of 292.08% is expected in the next year compared to the current price of 5.81.
KEMPHARM INC (KMPH) Forecast, Price Target & Analyst Ratings
NASDAQ:KMPH • US4884452065
Current stock price
5.81 USD
-0.02 (-0.34%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for KEMPHARM INC (KMPH).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Mar 28, 2023
- Period
- Q4 / 2022
- EPS Estimate
- -$0.18
- Revenue Estimate
- 3.264M
Price Target Details & History
Consensus Price Target and Range
Mean target
$22.78
Upside
+ 292.08%
From current price of $5.81 to mean target of $22.78, Based on 9 analyst forecasts
Low
$19.19
Median
$20.40
High
$29.40
Price Target Revisions
1 Month
0.00%
3 Months
14.53%
Price Target Summary
9 Wall Street analysts provided a forecast for the next 12 months for KMPH. The average price target is 22.78 USD. This implies a price increase of 292.08% is expected in the next year compared to the current price of 5.81.
The average price target has been revised upward by 14.53% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
84.44%
KMPH was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about KMPH.
In the previous month the buy percentage consensus was at a similar level.
KMPH was analyzed by 9 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-11-17 | Cantor Fitzgerald | Initiate | Overweight |
| 2022-09-15 | Canaccord Genuity | Initiate | Buy |
| 2022-08-17 | HC Wainwright & Co. | Maintains | Buy |
| 2022-01-31 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
| 2021-04-09 | HC Wainwright & Co. | Maintains | Neutral |
| 2021-03-04 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Mar 28, 2023
- Period
- Q4 / 2022
- EPS Estimate
- -$0.18
- Revenue Estimate
- 3.264M
- Revenue Q2Q
- 26.41%
- EPS Q2Q
- -121.00%
- Number of Analysts
- 5
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
KMPH is expected to report earnings on 3/28/2023. The consensus EPS estimate for the next earnings is -0.18 USD and the consensus revenue estimate is 3.26M USD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
Full Analyst Estimates 2022 - 2030
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 12.84M | 13.29M 3.50% | 28.65M 115.58% | 11.56M -59.65% | 18.768M 62.35% | 39.678M 111.41% | 60.261M 51.88% | 104.04M 72.65% | 126.01M 21.12% | 249.8M 98.24% | 344.3M 37.83% | 436.56M 26.80% | |
| EBITDA YoY % growth | -20.04M 63.68% | -4.93M 75.40% | 7.986M 261.99% | -39.372M -593.01% | -23.358M 40.67% | -19.992M 14.41% | 15.912M 179.59% | 54.162M 240.38% | 36.21M -33.15% | 160.24M 342.53% | 292.84M 82.75% | 417.59M 42.60% | |
| EBIT YoY % growth | -20.34M 63.35% | -5.2M 74.43% | 7.729M 248.63% | -40.443M -623.26% | -20.107M 50.28% | -10.353M 48.51% | 8.077M 178.02% | 43.412M 437.48% | 35.274M -18.75% | 117.35M 232.68% | 198.7M 69.32% | 277.44M 39.63% | |
| Operating Margin | -158.41% | -39.13% | 26.98% | -349.85% | -107.14% | -26.09% | 13.40% | 41.73% | 27.99% | 46.98% | 57.71% | 63.55% | |
| EPS YoY % growth | -11.84 80.63% | -3.31 72.04% | -0.46 86.10% | -1.12 -143.91% | -0.70 37.88% | -0.22 67.80% | 0.22 200.00% | 1.35 500.00% | 0.66 -50.76% | 2.65 300.00% | 4.46 68.08% | 6.26 40.50% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 22 | Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.18 -121.00% | -0.15 -206.00% | -0.15 19.47% | -0.14 24.84% | -0.14 19.23% |
| Revenue Q2Q % growth | 3.264M 26.41% | 3.978M 0.33% | 4.182M 221.69% | 4.488M 56.16% | 4.794M 46.88% |
| EBITDA Q2Q % growth | -6.018M -132.80% | -5.916M -229.77% | -5.814M 15.22% | -5.814M 2.81% | -5.814M 3.39% |
| EBIT Q2Q % growth | -6.614M -132.72% | -6.63M -256.64% | -6.63M 6.67% | -6.63M -0.06% | -6.528M 1.30% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
14.78%
EPS Next 5 Year
37.57%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
11.18%
Revenue Next 5 Year
29.23%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
-64.71%
EBIT Next 5 Year
46.24%
KEMPHARM INC / KMPH Forecast FAQ
When does KEMPHARM INC (KMPH) report earnings?
KEMPHARM INC (KMPH) will report earnings on 2023-03-28, before the market open.
What are the consensus estimates for KMPH stock next earnings?
The consensus EPS estimate for the next earnings of KEMPHARM INC (KMPH) is -0.18 USD and the consensus revenue estimate is 3.26M USD.
How many analysts have analysed KEMPHARM INC (KMPH)?
The number of analysts covering KEMPHARM INC (KMPH) is 9.